Timo Joensuu (born 27 February 1959 in Nokia,

Finland Finland ( fi, Suomi ; sv, Finland ), officially the Republic of Finland (; ), is a Nordic country in Northern Europe. It shares land borders with Sweden to the northwest, Norway to the north, and Russia to the east, with the Gulf of Bo ...

) is a Finnish oncologist, associate professor of clinical

oncology Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. A medical professional who practices oncology is an ''oncologist''. The name's etymological origin is the Greek word ὄγκος (''ó ...

University of Helsinki The University of Helsinki ( fi, Helsingin yliopisto, sv, Helsingfors universitet, abbreviated UH) is a public research university located in Helsinki, Finland since 1829, but founded in the city of Turku (in Swedish ''Åbo'') in 1640 as the ...

, researcher of new cancer treatments and developer of an internationally new hospital concept. He is a co-founder of Docrates Cancer Center in

Helsinki Helsinki ( or ; ; sv, Helsingfors, ) is the Capital city, capital, primate city, primate, and List of cities and towns in Finland, most populous city of Finland. Located on the shore of the Gulf of Finland, it is the seat of the region of U ...

and was its clinical director until 2014, after which he has been concentrating mostly on clinical work with the patients as the chief oncologist. Dr Joensuu studied medicine in the University of Tampere. He graduated MBBS and qualified professional MD 1986 and presented his doctoral thesis on cytodifferentiation in 1992. 1991–1993 he had a research fellowship in INSERM (Institut national de la santé et de la recherche médicale) in

Paris Paris () is the capital and most populous city of France, with an estimated population of 2,165,423 residents in 2019 in an area of more than 105 km² (41 sq mi), making it the 30th most densely populated city in the world in 2020. ...

. Joensuu specialized in

, radio therapy in Helsinki University Hospital where he worked 1991–2007. He has also been medical advisor for AstraZeneca and for Helsinki Consulting Group and World Bank in Serbia year 2004. Since 2007 he is the clinical director of Docrates Cancer Center and member of the board of directors of the company. Dr Joensuu has led several clinical trials and published articles on oncolytic adenovirus therapy, radiotherapy, chemoradiotherapy and prostate cancer. Dr Joensuu was the first doctor in Nordic countries to use IMRT (Intensity-modulated radiation therapy). At Docrates Cancer Center Dr Joensuu was especially devoted to the development of target radiotherapy, research and clinical trials. Dr.Joensuu has been on the Prostate Cancer Organisation Propo's board and participated in different international cancer research organizations as an expert. Dr Joensuus's vision is a fast track path from diagnosis to treatment, founded on the belief that cancer care can be carried out different way compared to traditional models.

References

{{DEFAULTSORT:Joensuu, Timo Finnish oncologists 1957 births People from Nokia, Finland Living people